SavedAdd your journal

Journals / Retina-Vitreus / 2020 / Cilt: 29 - Sayı: 4

Choroidal Vascularity Index in Patients with Chronic Central Serous Chorioretinopathy

Cumali DEGIRMENCI
Cezmi AKKIN
Semir YARIMADA
Serhad NALCACI
Filiz AFRASHI
Pages
301–305
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Also, choroidal vascular structural changes may occur in both eyes of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate choroidal vascular structure and choroidal thickness in patients with chronic central serous chorioretinopathy.Materials and Methods: Thirty-four eyes of 34 patients with unilateral chronic central serous chorioretinopathy (Group 1; involved eyes, Group 2; fellow eyes) and 28 right eyes of 28 age and gender matched subjects (Group 3) were included to study.
📊
Key Findings & Data:Choroidal thickness, total choroidal area, luminal area, stromal area and choroidal vascularity index were calculated with Image J program.Results: The mean choroidal thickness was 411.47±120.16 (228-674) in Group 1 376.64±73.345 (213-578) in Group 2 and 289.93±47.495 (220-372) in Group 3.
💡
Conclusion & Impact:Also, choroidal vascular structural changes may occur in both eyes of patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Purpose: To evaluate choroidal vascular structure and choroidal thickness in patients with chronic central serous chorioretinopathy.Materials and Methods: Thirty-four eyes of 34 patients with unilateral chronic central serous chorioretinopathy (Group 1; involved eyes, Group 2; fellow eyes) and 28 right eyes of 28 age and gender matched subjects (Group 3) were included to study. All participants underwent a detailed ophthalmic examination and an optical coherence tomography obtained by enhanced dept imaging mode (EDI-OCT). Choroidal thickness, total choroidal area, luminal area, stromal area and choroidal vascularity index were calculated with Image J program.Results: The mean choroidal thickness was 411.47±120.16 (228-674) in Group 1 376.64±73.345 (213-578) in Group 2 and 289.93±47.495 (220-372) in Group 3. Choroidal thickness was signifi cantly higher in Group 1 and 2 than Group 3, but it was statistically similar between Group1 and 2. The mean total choroidal area was 1.66±0.48 (0.58-2.51) in Group 1, 1.60±0.54 (0.63-2.68) in Group 2 and 1.39±0.26 (0.99-1.94) in Group 3. Total choroidal area, luminal area and choroidal vascularity index were signifi cantly higher in Group 1 and Group 2. Choroidal vascularity indexes were 0.55±0.26 (0.18-0.64), 0.34±0.06 (0.17-0.42), 0.28±0.04 (0.20-0.35) in Group 1, 2 and 3, respectively. It was signifi cantly higher in Group 1 and 2 than Group 3.Conclusion: Choroidal thickness was increased in patients with central serous chorioretinopathy and their fellow eyes. Also, choroidal vascular structural changes may occur in both eyes of patients.

🔖

Cite This Article

DEGIRMENCI, C., AKKIN, C., YARIMADA, S., NALCACI, S., AFRASHI, F. (2020). Choroidal Vascularity Index in Patients with Chronic Central Serous Chorioretinopathy. Retina-Vitreus, Cilt: 29 - Sayı: 4, 301–305. https://ajindex.com/articles/304780

References (15)

  1. Liegl R, Ulbig MW. Central serous chorioretinopathy. Ophthalmologica. 2014; 232:65-76
  2. Iacono P, Battaglia, Parodi M, et al. Central Serous Chorioretinopathy Treatments: A Mini Review. Ophthalmic Res. 2015; 55:76-83
  3. Nicholson BP, Atchison E, Idris AA, et al. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. Surv Ophthalmol. 2018; 63:1-8
  4. Nicholson B, Noble J, Forooghian F, et al. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013; 58:103-26
  5. Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy: Recent fi ndings and new physiopathology hypothesis. Prog Retin Eye Res.2015; 48:82-118
  6. Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol. 2008; 86:126-45
  7. Hanumunthadu D, Tan ACS, Singh SR, et al. Management of chronic central serous chorioretinopathy. Indian journal of ophthalmology. 2018; 66:1704-14
  8. Borrelli E, Sarraf D, Freund KB, et al. OCT angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res. 2018; 67:30-55
  9. Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol. 2013; 58:387- 429
  10. Chhablani J, Barteselli G. Clinical applications of choroidal imaging technologies. Indian journal of ophthalmology. 2015; 63:384-90
  11. Sonoda S, Sakamoto T, Yamashita T, et al. Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Invest Ophthalmol Vis Sci. 2014; 55:3893-9
  12. Agrawal R, Chhablani J, Tan KA, et al. Choroidal vascularity index in central serous chorioretinopathy. Retina. 2016; 36:1646-51
  13. Ruiz-Medrano J, Pellegrini M, Cereda MG, et al. Choroidal characteristics of acute and chronic central serous chorioretinopathy using enhanced depth imaging optical coherence tomography. Eur J Ophthalmol. 2017; 27:476-80
  14. Sezer T, Altınışık M, Koytak İA, et al. The Choroid and Optical Coherence Tomography. Turk J Ophthalmol. 2016;46:30-37 15. Batıoğlu F, Aydın A, Atmaca L. Optıc Coherence Tomography For Dıagnosıs And Follow-Up Of Central Serous Chorıoretnopathy. Retina- Vitreous Journal. 2002; 10:2 16. Rasheed MA Goud A, Mohamed A, et al. Change in choroidal vascularity in acute central serous chorioretinopathy. Indian journal of ophthalmology. 2018; 66:530-4
  15. Demirel S, Ozcan G, Yanik O, et al. Vascular and structural alteratio